Thu, November 10, 2022
Wed, November 9, 2022
Tue, November 8, 2022
Mon, November 7, 2022

Douglas Tsao Maintained (TBPH) at Strong Buy with Increased Target to $19 on, Nov 8th, 2022


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. with-increased-target-to-19-on-nov-8th-2022.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Douglas Tsao of HC Wainwright & Co., Maintained "Theravance Biopharma, Inc." (TBPH) at Strong Buy with Increased Target from $12 to $19 on, Nov 8th, 2022.

Douglas has made no other calls on TBPH in the last 4 months.



There is 1 other peer that has a rating on TBPH. Out of the 1 peers that are also analyzing TBPH, 0 agree with Douglas's Rating of Hold.



This is the rating of the analyst that currently disagrees with Douglas


  • Vikram Purohit of "Morgan Stanley" Maintained at Sell with Decreased Target to $10 on, Monday, July 25th, 2022

Publication Contributing Sources